Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NFX88 for Neuropathic Pain in Spinal Cord Injury
NCT04148573Phase 2Completed
- Sponsor
- Neurofix Pharma
- Start
- Oct 2019
- Primary completion
- May 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of 2-hydroxyoleic acid in neuropathic pain, sponsored by Neurofix Pharma. Started Oct 2019; status: completed.
02
Drugs
2-hydroxyoleic acid
03
Conditions
neuropathic pain
Beyond the preview
Go deeper on NCT04148573.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04148573.